KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 74 filers reported holding KALA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 1,597 | +27.9% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1,249 | -68.9% | 0.00% | – |
| Q1 2022 | $5,000 | -64.3% | 4,021 | -63.8% | 0.00% | – |
| Q4 2021 | $14,000 | -17.6% | 11,101 | +73.8% | 0.00% | – |
| Q3 2021 | $17,000 | -32.0% | 6,386 | +42.0% | 0.00% | – |
| Q2 2021 | $25,000 | -3.8% | 4,497 | +13.1% | 0.00% | – |
| Q1 2021 | $26,000 | +62.5% | 3,975 | +73.5% | 0.00% | – |
| Q4 2020 | $16,000 | +433.3% | 2,291 | +420.7% | 0.00% | – |
| Q3 2020 | $3,000 | -76.9% | 440 | -63.6% | 0.00% | – |
| Q2 2020 | $13,000 | +550.0% | 1,208 | +325.4% | 0.00% | – |
| Q1 2020 | $2,000 | -60.0% | 284 | -76.6% | 0.00% | – |
| Q4 2019 | $5,000 | +400.0% | 1,213 | +500.5% | 0.00% | – |
| Q3 2019 | $1,000 | -87.5% | 202 | -83.8% | 0.00% | – |
| Q2 2019 | $8,000 | +700.0% | 1,250 | +681.2% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 160 | +6.7% | 0.00% | – |
| Q4 2018 | $1,000 | -66.7% | 150 | -57.5% | 0.00% | – |
| Q3 2018 | $3,000 | +50.0% | 353 | +135.3% | 0.00% | – |
| Q2 2018 | $2,000 | -90.0% | 150 | -88.0% | 0.00% | – |
| Q1 2018 | $20,000 | +900.0% | 1,254 | +1117.5% | 0.00% | – |
| Q4 2017 | $2,000 | -88.2% | 103 | -85.9% | 0.00% | – |
| Q3 2017 | $17,000 | – | 731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,333,333 | $5,073,000 | 100.00% |
| CAXTON CORP | 1,483,343 | $5,644,000 | 6.36% |
| Polaris Venture Management Co. V, L.L.C. | 1,197,032 | $4,555,000 | 2.59% |
| RA Capital Management | 4,537,478 | $17,265,000 | 1.03% |
| Orbimed Advisors | 3,447,840 | $13,119,000 | 0.25% |
| Matisse Capital | 46,500 | $177,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 332,831 | $1,266,000 | 0.22% |
| Sofinnova Investments, Inc. | 478,206 | $1,819,000 | 0.16% |
| HARBOURVEST PARTNERS LLC | 99,186 | $377,000 | 0.16% |
| ALGERT GLOBAL LLC | 47,195 | $180,000 | 0.07% |